Brief: Jacobio Pharmaceuticals Received U.S. FDA Investigational New Drug Clearance

Jacobio Pharmaceuticals

01/03/2024 07:15

March 1 (Reuters) - Jacobio Pharmaceuticals Group Co Ltd
 1167.HK :
    * RECEIVED US FDA INVESTIGATIONAL NEW DRUG CLEARANCE FOR P53
Y220C
ACTIVATOR JAB-30300
    * PLANS TO INITIATE PHASE I/IIA ADVANCED SOLID TUMORS
CLINICAL
TRIAL IN U.S. OF JAB-30300
    * PLANS TO SUBMIT IND APPLICATION TO CENTER FOR DRUG
EVALUATION OF
NMPA IN CHINA FOR JAB-30300
    * WILL CONDUCT CLINICAL STUDIES IN BOTH CHINA AND U.S. ON
IND
APPROVAL FOR JAB-30300

Further company coverage:  1167.HK 

 ((Reuters.Briefs@thomsonreuters.com;))